Redmile Group’s Gritstone bio, Inc. Common Stock GRTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-4,920,178
Closed -$2.85M 65
2024
Q3
$2.85M Sell
4,920,178
-187,554
-4% -$105K 0.17% 55
2024
Q2
$3.16M Sell
5,107,732
-647,343
-11% -$547K 0.19% 54
2024
Q1
$14.8M Sell
5,755,075
-117,530
-2% -$287K 0.54% 47
2023
Q4
$12M Sell
5,872,605
-2,636,521
-31% -$4.81M 0.43% 48
2023
Q3
$14.6M Buy
8,509,126
+1,648,900
+24% +$2.93M 0.7% 34
2023
Q2
$13.4M Sell
6,860,226
-66,700
-1% -$156K 0.51% 44
2023
Q1
$19.3M Sell
6,926,926
-4,534
-0.1% -$13K 0.84% 42
2022
Q4
$23.9M Sell
6,931,460
-21,300
-0.3% -$60.8K 0.98% 30
2022
Q3
$17.9M Hold
6,952,760
0.69% 42
2022
Q2
$16.8M Buy
6,952,760
+81,022
+1% +$213K 0.64% 41
2022
Q1
$28.3M Buy
6,871,738
+3,442,567
+100% +$18.2M 0.88% 33
2021
Q4
$44.1M Buy
3,429,171
+608,086
+22% +$6.73M 1% 31
2021
Q3
$30.5M Buy
2,821,085
+594,879
+27% +$5.41M 0.53% 46
2021
Q2
$20.3M Sell
2,226,206
-221,952
-9% -$2.05M 0.3% 65
2021
Q1
$23.1M Sell
2,448,158
-611,636
-20% -$8.42M 0.33% 63
2020
Q4
$12.1M Hold
3,059,794
0.15% 70
2020
Q3
$8.11M Sell
3,059,794
-5,200
-0.2% -$19.3K 0.15% 71
2020
Q2
$20.4M Sell
3,064,994
-3,200
-0.1% -$21.6K 0.38% 60
2020
Q1
$17.9M Sell
3,068,194
-48,400
-2% -$406K 0.5% 48
2019
Q4
$28M Buy
3,116,594
+12,100
+0.4% +$101K 0.67% 40
2019
Q3
$26.8M Sell
3,104,494
-111,500
-3% -$1.13M 0.9% 35
2019
Q2
$35.8M Buy
3,215,994
+862,259
+37% +$9.86M 1.01% 28
2019
Q1
$31.3M Buy
2,353,735
+84,599
+4% +$1.13M 0.92% 38
2018
Q4
$35.1M Buy
2,269,136
+26,500
+1% +$506K 1.41% 26
2018
Q3
$31.9M Buy
+2,242,636
New +$31.9M 0.98% 37

Other funds holding GRTS

Redmile Group's GRTS Position: Q4 2024 in Review

Redmile Group sold out of Gritstone bio, Inc. Common Stock (GRTS) in Q4 2024, closing a stake of 4,920,178 shares — an estimated $2.85M sold.

Redmile Group first reported a position in GRTS in Q3 2018 and held it in 25 quarters. The position peaked at $44.1M in Q4 2021. 6 funds tracked by Wall St. Rank hold GRTS as of Q4 2024.

  • Redmile Group reported no remaining Gritstone bio, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
  • Redmile Group sold 4,920,178 Gritstone bio, Inc. Common Stock shares in Q4 2024, an estimated $2.85M.
  • Redmile Group first reported a position in Gritstone bio, Inc. Common Stock in Q3 2018 and held it in 25 quarters.
  • Redmile Group's Gritstone bio, Inc. Common Stock position peaked at $44.1M in Q4 2021.
  • 6 funds tracked by Wall St. Rank held Gritstone bio, Inc. Common Stock as of Q4 2024.

Based on Redmile Group's 13F filing for Q4 2024, filed 14 Feb 2025.